Literature DB >> 2868992

Isolation of the outer membrane components of Bordetella pertussis which enhance the immunogenicity of Haemophilus influenzae type b capsular polysaccharide polyribosyl ribitol phosphate.

N Monji, M R Stebbins, D W McCoy, J S Kuo.   

Abstract

The outer membrane (OM) component(s) from Bordetella pertussis which potentiated the antigenicity of purified Haemophilus influenzae type b capsular polysaccharide, polyribosyl ribitol phosphate (PRP), has been isolated and partially characterized. The OM was isolated from spheroplasting medium by precipitating at pH 5.0; fractionation was carried out by dissolving the crude OM in Triton X-100 followed by selective precipitation of OM in 50% ethanol. Further purification of OM was accomplished by DEAE-Sepharose 6BCL and Sephacryl S-300 chromatography. The biochemical composition and protein profiles on sodium dodecyl sulfate-polyacrylamide gel electrophoresis of various OM preparations have been examined. Combined vaccines consisting of OM components and PRP were given to young Sprague-Dawley rats, and the serum antibody to PRP was measured by an [3H]PRP binding assay. The purified OM containing mainly a 30,000-dalton protein, but not purified lipopolysaccharide or leukocytosis-promoting toxin, exhibited strong enhancement of PRP immunogenicity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2868992      PMCID: PMC260978          DOI: 10.1128/iai.51.3.865-871.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  The effect of Bordetella pertussis on the antibody response in mice to type III pneumococcal polysaccharide.

Authors:  A S Kong; S I Morse
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

2.  Relationship of the anaphylaxis sensitizing and adjuvant properties of Hemophilus pertussis vaccine.

Authors:  L S KIND
Journal:  J Immunol       Date:  1957-09       Impact factor: 5.422

3.  Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis.

Authors:  R K Bergman; J J Munoz; J L Portis
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Separation and characterization of the outer membrane of Pseudomonas aeruginosa.

Authors:  T Mizuno; M Kageyama
Journal:  J Biochem       Date:  1978-07       Impact factor: 3.387

6.  Modification of antibody response to type III pneumopolysaccharide by route of injection of pertussis vaccine.

Authors:  R S Speirs; R W Benson; D W Roberts
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Simple charring method for determination of lipids.

Authors:  J B Marsh; D B Weinstein
Journal:  J Lipid Res       Date:  1966-07       Impact factor: 5.922

8.  A radioactive antigen-binding assay for the measurement of antibody to Haemophilus influenzae type b capsular polysaccharide.

Authors:  J S Kuo; N Monji; R S Schwalbe; D W McCoy
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

9.  Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.

Authors:  H Peltola; H Käyhty; A Sivonen; H Mäkelä
Journal:  Pediatrics       Date:  1977-11       Impact factor: 7.124

10.  Evidence for covalent attachment of phospholipid to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  J S Kuo; V W Doelling; J F Graveline; D W McCoy
Journal:  J Bacteriol       Date:  1985-08       Impact factor: 3.490

View more
  1 in total

Review 1.  Stem Cells in Functional Bladder Engineering.

Authors:  Jakub Smolar; Souzan Salemi; Maya Horst; Tullio Sulser; Daniel Eberli
Journal:  Transfus Med Hemother       Date:  2016-08-31       Impact factor: 3.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.